Clinical Trial Update: Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling [EARLY_Phase 1]

View source ↗

Summary

This early-phase clinical trial aims to determine red blood cell survival in sickle cell disease and other hemoglobinopathies using biotin labeling. The study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemoglobinopathy
• Sickle Cell Disease
• Thalassemia

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Sickle Cell Disease, Thalassemia | EARLY_Phase 1 | Status: RECRUITING